The DOI matches its Crossref record; 88 of the 88 references it cites were found in a registry or an index.
Nanostructured lipid carriers system: Recent advances in drug delivery
Abstract
Nanostructured lipid carrier (NLC) is second generation smarter drug carrier system having solid matrix at room temperature. This carrier system is made up of physiological, biodegradable and biocompatible lipid materials and surfactants and is accepted by regulatory authorities for application in different drug delivery systems. The availability of many products in the market in short span of time reveals the success story of this delivery system. Since the introduction of the first product, around 30 NLC preparations are commercially available. NLC exhibit superior advantages over other colloidal carriers viz., nanoemulsions, polymeric nanoparticles, liposomes, SLN etc. and thus, have been explored to more extent in pharmaceutical technology. The whole set of unique advantages such as enhanced drug loading capacity, prevention of drug expulsion, leads to more flexibility for modulation of drug release and makes NLC versatile delivery system for various routes of administration. The present review gives insights on the definitions and characterization of NLC as colloidal carriers including the production techniques and suitable formulations. This review paper also highlights the importance of NLC in pharmaceutical applications for the various routes of drug delivery viz., topical, oral, pulmonary, ocular and parenteral administration and its future perspective as a pharmaceutical carrier.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Solid lipid nanoparticles (SLN) for controlled drug delivery â a review of the state of the art
Müller, R. (2000) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/s0939-6411(00)00087-4 · Cited by 3,759
Solid lipid nanoparticles Production, characterization and applications
Mehnert, W. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(01)00105-3 · Cited by 3,150
Müller, R. H., Radtke, M., & Wissing, S. A. (2002) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00118-7 · Cited by 2,113
Lipid nanoparticles (SLN, NLC) in cosmetic and pharmaceutical dermal products
Pardeike, J., Hommoss, A., & Müller, R. H. (2009) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2008.10.003 · Cited by 1,478
Foye's Principles of Medicinal Chemistry
Foye, W. O., Lemke, T., & Williams, D. A. (2012) · Cited by 1,407
Nanostructured lipid matrices for improved microencapsulation of drugs
Müller, R. H., Radtke, M., & Wissing, S. A. (2002) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(02)00180-1 · Cited by 1,226
Design and production of nanoparticles formulated from nano-emulsion templates-A review
Anton, N., Benoit, J.-P., & Saulnier, P. (2008) · Journal of Controlled Release · doi:10.1016/j.jconrel.2008.02.007 · Cited by 1,226
Solid lipid nanoparticles (SLN) for controlled drug delivery – Drug release and release mechanism
zur Mühlen, A., Schwarz, C., & Mehnert, W. (1998) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/s0939-6411(97)00150-1 · Cited by 945
Recent Advances in Lipid Nanoparticle Formulations with Solid Matrix for Oral Drug Delivery
Das, S., & Chaudhury, A. (2011) · AAPS PharmSciTech · doi:10.1208/s12249-010-9563-0 · Cited by 838
Nanostructured lipid carriers (NLC) in cosmetic dermal products☆
MULLER, R., PETERSEN, R., HOMMOSS, A., & PARDEIKE, J. (2007) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.04.012 · Cited by 700
Souto, E. B., Wissing, S. A., Barbosa, C. M., & Müller, R. H. (2004) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2004.02.032 · Cited by 692
Freitas, C., & Müller, R. H. (1998) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(98)00092-1 · Cited by 687
Charman, W. N., Porter, C. J. H., Mithani, S., & Dressman, J. B. (1997) · Journal of Pharmaceutical Sciences · doi:10.1021/js960085v · Cited by 617 · cited 1×
“Intensive studies about the correlation between absorption enhancement © 2012 Informa UK, Ltd. and types of lipids have been made by Charman and associates (Charman et al., 1997; Charman, 2000).”
BackgroundA Novel Phase Inversion-Based Process for the Preparation of Lipid Nanocarriers
Heurtault, B., Saulnier, P., Pech, B., Proust, J.-E., & Benoit, J.-P. (2002) · Pharmaceutical Research · doi:10.1023/a:1016121319668 · Cited by 583
Vitamin Analysis for the Health and Food Sciences
Eitenmiller, R., & Landen, W. (1998) · CRC Press eBooks · doi:10.1201/9781420050165 · Cited by 546
20 Years of Lipid Nanoparticles (SLN & NLC): Present State of Development & Industrial Applications
H. Muller, R., Shegokar, R., & M. Keck, C. (2011) · Current Drug Discovery Technologies · doi:10.2174/157016311796799062 · Cited by 544
Üner, M., & Yener, G. (2007) · PubMed Central · Cited by 543
Fang, J.-Y., Fang, C.-L., Liu, C.-H., & Su, Y.-H. (2008) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2008.05.008 · Cited by 518
Schubert, M. (2003) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/s0939-6411(02)00130-3 · Cited by 454
Preparation of solid lipid nanoparticles by a solvent emulsification–diffusion technique
Trotta, M., Debernardi, F., & Caputo, O. (2003) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(03)00135-2 · Cited by 439
Crystallization tendency and polymorphic transitions in triglyceride nanoparticles
Bunjes, H., Westesen, K., & Koch, M. H. J. (1996) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(95)04286-5 · Cited by 425
In vitro uptake of polystyrene microspheres: effect of particle size, cell line and cell density
Zauner, W., Farrow, N. A., & Haines, A. M. R. (2001) · Journal of Controlled Release · doi:10.1016/s0168-3659(00)00358-8 · Cited by 411
Solid lipid nanoparticles (SLN) as ocular delivery system for tobramycin
Cavalli, R., Gasco, M. R., Chetoni, P., Burgalassi, S., & Saettone, M. F. (2002) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(02)00080-7 · Cited by 389
Local anesthetics : mechanisms of action and clinical use
Covino, B. G., & Vassallo, H. (1976) · Medical Entomology and Zoology · Cited by 354
Lipoic acid - the drug of the future?
Bilska‐Wilkosz, A., & Włodek, L. B. (2005) · PubMed · Cited by 349
Exploring solid lipid nanoparticles to enhance the oral bioavailability of curcumin
Kakkar, V., Singh, S., Singla, D., & Kaur, I. P. (2011) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201000310 · Cited by 348
Teeranachaideekul, V., Souto, E. B., Junyaprasert, V. B., & Müller, R. H. (2007) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2007.01.015 · Cited by 323
Pandey, R., & Khuller, G. K. (2005) · Tuberculosis · doi:10.1016/j.tube.2004.11.003 · Cited by 318
Zhuang, C.-Y., Li, N., Wang, M., Zhang, X.-N., Pan, W.-S., Peng, J.-J., Pan, Y.-S., & Tang, X. (2010) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2010.05.005 · Cited by 318
Oral bioavailability of cyclosporine: Solid lipid nanoparticles (SLN®) versus drug nanocrystals
Müller, R. H., Runge, S., Ravelli, V., Mehnert, W., Thünemann, A. F., & Souto, E. B. (2006) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2006.02.045 · Cited by 304
Nanostructured lipid carrier (NLC) based gel of celecoxib
Joshi, M., & Patravale, V. (2008) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2007.05.060 · Cited by 302
Paliwal, R., Rai, S., Vaidya, B., Khatri, K., Goyal, A. K., Mishra, N., Mehta, A., & Vyas, S. P. (2009) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2008.08.003 · Cited by 288
MEASUREMENT OF TOTAL LUNG DEPOSITION OF INHALED ULTRAFINE PARTICLES IN HEALTHY MEN AND WOMEN
Peter A. Jaques, C. S. K. (2000) · Inhalation Toxicology · doi:10.1080/08958370050085156 · Cited by 287
Preparation of solid lipid nanoparticles using a membrane contactor
Charcosset, C., El-Harati, A., & Fessi, H. (2005) · Journal of Controlled Release · doi:10.1016/j.jconrel.2005.07.023 · Cited by 250
Patlolla, R. R., Chougule, M., Patel, A. R., Jackson, T., Tata, P. N. V., & Singh, M. (2010) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.02.006 · Cited by 250
TEERANACHAIDEEKUL, V, MULLER, R., & JUNYAPRASERT, V (2007) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2007.03.022 · Cited by 250
Liposome coated with low molecular weight chitosan and its potential use in ocular drug delivery
Li, N., Zhuang, C., Wang, M., Sun, X., Nie, S., & Pan, W. (2009) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2009.06.020 · Cited by 245
Nanostructured lipid carriers as novel carrier for parenteral delivery of docetaxel
Liu, D., Liu, Z., Wang, L., Zhang, C., & Zhang, N. (2011) · Colloids and Surfaces B: Biointerfaces · doi:10.1016/j.colsurfb.2011.02.038 · Cited by 245
Phase I/II clinical and pharmacokinetic evaluation of liposomal daunorubicin.
Gill, P. S., Espina, B. M., Muggia, F., Cabriales, S., Tulpule, A., Esplin, J. A., Liebman, H. A., Forssen, E., Ross, M. E., & Levine, A. M. (1995) · Journal of Clinical Oncology · doi:10.1200/jco.1995.13.4.996 · Cited by 242
Effects of Skin Occlusion on Percutaneous Absorption: An Overview
Zhai, H., & Maibach, H. I. (2001) · Skin Pharmacology and Physiology · doi:10.1159/000056328 · Cited by 235
Alveolar clearance and the role of the pulmonary lymphatics.
Lauweryns, J. M., & Baert, J. H. (1977) · PubMed · doi:10.1164/arrd.1977.115.4.625 · Cited by 233
Lipids, Lipophilic Drugs, and Oral Drug Delivery—Some Emerging Concepts
Charman, W. N. (2000) · Journal of Pharmaceutical Sciences · doi:10.1002/1520-6017(200008)89:8<967::aid-jps1>3.0.co;2-r · Cited by 224
Optimization of nanostructured lipid carriers for lutein delivery
Liu, C.-H., & Wu, C.-T. (2010) · Colloids and Surfaces A: Physicochemical and Engineering Aspects · doi:10.1016/j.colsurfa.2009.11.006 · Cited by 222
Pardeike, J., Weber, S., Haber, T., Wagner, J., Zarfl, H. P., Plank, H., & Zimmer, A. (2011) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2011.07.040 · Cited by 216
α-Lipoic Acid and Cardiovascular Disease
Wollin, S. D., & Jones, P. J. H. (2003) · The Journal of Nutrition · doi:10.1093/jn/133.11.3327 · Cited by 216
Sjöström, B., & Bergenståhl, B. (1992) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(92)90303-j · Cited by 215
Yuan, H., Wang, L.-L., Du, Y.-Z., You, J., Hu, F.-Q., & Zeng, S. (2007) · Colloids and Surfaces B: Biointerfaces · doi:10.1016/j.colsurfb.2007.06.011 · Cited by 215
Kumar, V. V., Chandrasekar, D., Ramakrishna, S., Kishan, V., Rao, Y. M., & Diwan, P. V. (2007) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2006.11.004 · Cited by 213
Shidhaye, S., Vaidya, R., Sutar, S., Patwardhan, A., & Kadam, V. (2008) · Current Drug Delivery · doi:10.2174/156720108785915087 · Cited by 210
Packer, L. (1998) · Drug Metabolism Reviews · doi:10.3109/03602539808996311 · Cited by 207
Stability of lipid excipients in solid lipid nanoparticles☆
RADOMSKASOUKHAREV, A. (2007) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.04.004 · Cited by 205
Polymorphic behaviour of Compritol®888 ATO as bulk lipid and as SLN and NLC
Souto, E. B., Mehnert, W., & Müller, R. H. (2006) · Journal of Microencapsulation · doi:10.1080/02652040600612439 · Cited by 204
HUANG, Z.-R., HUA, S.-C., YANG, Y.-L., & FANG, J.-Y. (2008) · Acta Pharmacologica Sinica · doi:10.1111/j.1745-7254.2008.00829.x · Cited by 200
MULLER, R. (2008) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2007.07.006 · Cited by 199
Lipid Nanoparticles (SLN®, NLC®) for Cutaneous Drug Delivery:Structure, Protection and Skin Effects
Souto, E. B., Almeida, A. J., & Müller, R. H. (2007) · Journal of Biomedical Nanotechnology · doi:10.1166/jbn.2007.049 · Cited by 186
Nanoparticulate Drug Delivery Systems
(2007) · CRC Press eBooks · doi:10.1201/9781420008449 · Cited by 171
Atomic Force Microscopy Studies of Solid Lipid Nanoparticles
Mühlen, A. Z., Mühlen, E. Z., Niehus, H., & Mehnert, W. (1996) · Pharmaceutical Research · doi:10.1023/a:1016042504830 · Cited by 163
α-Lipoic Acid in the Treatment of Diabetic Peripheral and Cardiac Autonomic Neuropathy
Ziegler, D., & Gries, F. A. (1997) · Diabetes · doi:10.2337/diab.46.2.s62 · Cited by 163
Gavini, E., Chetoni, P., Cossu, M., Alvarez, M. G., Saettone, M. F., & Giunchedi, P. (2004) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2003.10.018 · Cited by 160
Combination of calcipotriol and methotrexate in nanostructured lipid carriers for topical delivery
Fang, J. (2010) · International Journal of Nanomedicine · doi:10.2147/ijn.s9155 · Cited by 159
Shahgaldian, P., Da Silva, E., Coleman, A. W., Rather, B., & Zaworotko, M. J. (2003) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(02)00639-7 · Cited by 158
Cirri, M., Bragagni, M., Mennini, N., & Mura, P. (2012) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2011.07.015 · Cited by 155
Preservation of nanostructured lipid carriers (NLC)
Obeidat, W. M., Schwabe, K., Müller, R. H., & Keck, C. M. (2010) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2010.05.001 · Cited by 155
Formulation of a Novel Oxybenzone-Loaded Nanostructured Lipid Carriers (NLCs)
Sanad, R. A.-B., Abdelmalak, N. S., elBayoomy, T. S., & Badawi, A. A. E.-L. (2010) · AAPS PharmSciTech · doi:10.1208/s12249-010-9553-2 · Cited by 150
Development of topotecan loaded lipid nanoparticles for chemical stabilization and prolonged release
de Souza, L. G., Silva, E. J., Martins, A. L. L., da Mota, M. F., Braga, R. C., Lima, E. M., Valadares, M. C., Taveira, S. F., & Marreto, R. N. (2011) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2011.02.012 · Cited by 146
Ricci, M., Puglia, C., Bonina, F. P., Giovanni, C. D., Giovagnoli, S., & Rossi, C. R. (2005) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.20335 · Cited by 143
Štecová, J., Mehnert, W., Blaschke, T., Kleuser, B., Sivaramakrishnan, R., Zouboulis, C. C., Seltmann, H., Körting, H. C., Kramer, K. D., & Schäfer‐Korting, M. (2007) · Pharmaceutical Research · doi:10.1007/s11095-006-9225-9 · Cited by 140
Tsai, M.-J., Huang, Y.-B., Wu, P.-C., Fu, Y.-S., Kao, Y.-R., Fang, J.-Y., & Tsai, Y.-H. (2011) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.22285 · Cited by 137 · cited 1×
“Electron microscopy such as scanning electron microscopy (SEM), transmission electron microscopy (TEM), and atomic force microscopy (AFM) are very useful techniques to determine the particle size and morphology of lipid nanoparticles (Tsai et al., 2011, Paliwal et al., 2009).”
MethodFormulation and Evaluation of Lidocaine Lipid Nanosystems for Dermal Delivery
Pathak, P. O., & Nagarsenker, M. S. (2009) · AAPS PharmSciTech · doi:10.1208/s12249-009-9287-1 · Cited by 137
Jia, L., Zhang, D., Li, Z., Duan, C., Wang, Y., Feng, F., Wang, F., Liu, Y., & Zhang, Q. (2010) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2010.06.008 · Cited by 136
Baboota, S., Shah, F. M., Javed, A., & Alka, A. (2009) · Journal of drug targeting · doi:10.1080/10611860902718672 · Cited by 128
Self-citationThatipamula, R. P., Palem, C., Gannu, R., et al. (2011) · PubMed · Cited by 121
Pople, P. V., & Singh, K. K. (2011) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2011.02.016 · Cited by 119
Ruktanonchai, U., Bejrapha, P., Sakulkhu, U., Opanasopit, P., Bunyapraphatsara, N., Junyaprasert, V. B., & Puttipipatkhachorn, S. (2009) · AAPS PharmSciTech · doi:10.1208/s12249-009-9193-6 · Cited by 93
Öğretmen, B., & Safa, A. R. (1999) · Biochemistry · doi:10.1021/bi982236+ · Cited by 86
The use of SLN and NLC as topical particulate carriers for imidazole antifungal agents.
Souto, E. B., & Müller, R. H. (2006) · PubMed · Cited by 83
Xie, S., Pan, B., Wang, M., Zhu, L., Wang, F., Dong, Z., Wang, X., & Zhou, W. (2010) · Nanomedicine · doi:10.2217/nnm.10.42 · Cited by 72
Marquele‐Oliveira, F., de Santana, D. C. A. S., Taveira, S. F., Vermeulen, D. M., de Oliveira, A. R. M., da Silva, R. S., & Lopez, R. F. V. (2010) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2010.06.007 · Cited by 68
Cook, N., & Freeman, S. (2001) · Australasian Journal of Dermatology · doi:10.1046/j.1440-0960.2001.00531.x · Cited by 68
A new oral testosterone undecanoate formulation
K�hn, F.-M., & Schill, W. (2003) · World Journal of Urology · doi:10.1007/s00345-003-0372-x · Cited by 57
The dispersed states of medicinal molecules in ground mixtures with .ALPHA.- or .BETA.-cyclodextrin.
Nakai, Y., Yamamoto, K., Terada, K., & Akimoto, K. (1984) · Chemical and Pharmaceutical Bulletin · doi:10.1248/cpb.32.685 · Cited by 54
Silva, A. C., Santos, D. F. G., Ferreira, D., & Souto, E. B. (2009) · Die Pharmazie · doi:10.31083/ph.2009.8232 · Cited by 50
Influence of anatomical site and topical formulation on skin penetration of sunscreens.
Benson, H. A. E., Sarveiya, V., Risk, S., & Roberts, M. S. (2005) · PubMed Central · Cited by 50
Jacobsen, W., Kirchner, G. I., Hallensleben, K., Mancinelli, L., Deters, M., Hackbarth, I., Baner, K., Benet, L. Z., Sewing, K., & Christians, U. (1999) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)35080-3 · Cited by 46
Preparation of submicron drug particles in lecithin-stabilized o/w emulsions
Sjöström, B., Westesen, K., & Bergenståhl, B. (1993) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(93)90013-6 · Cited by 42
Patel, M. M., Jain, S. K., Yadav, A. K., Gogna, D., & Agrawal, G. P. (2006) · Drug Delivery · doi:10.1080/10717540500398175 · Cited by 42
Liu, D., Liu, C., Zou, W., & Zhang, N. (2009) · Journal of Nanoparticle Research · doi:10.1007/s11051-009-9648-4 · Cited by 41
SLN and NLC for topical delivery of antifungals
Souto, E. B. (2005) · Universitätsbibliothek der FU Berlin Hochschulschriftenstelle u. Dokumentenserver · doi:10.17169/refubium-12273 · Cited by 25
Cited by
Tenchov, R., Bird, R., Curtze, A. E., & Zhou, Q. (2021) · ACS Nano · doi:10.1021/acsnano.1c04996 · Cited by 2,221
Nanomaterials for cancer therapy: current progress and perspectives
Cheng, Z., Li, M., Dey, R., & Chen, Y. (2021) · Journal of Hematology & Oncology · doi:10.1186/s13045-021-01096-0 · Cited by 1,168
Dependence of Nanoparticle Toxicity on Their Physical and Chemical Properties
Sukhanova, A., Bozrova, S., Sokolov, P., Berestovoy, M., Karaulov, A., & Nabiev, I. (2018) · Nanoscale Research Letters · doi:10.1186/s11671-018-2457-x · Cited by 1,107
Nanostructured lipid carriers: Promising drug delivery systems for future clinics
Beloqui, A., Solinís, M. Á., Rodríguez-Gascón, A., Almeida, A. J., & Préat, V. (2016) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2015.09.004 · Cited by 769
Lipid-Based Drug Delivery Systems in Cancer Therapy: What Is Available and What Is Yet to Come
Yingchoncharoen, P., Kalinowski, D. S., & Richardson, D. R. (2016) · Pharmacological Reviews · doi:10.1124/pr.115.012070 · Cited by 744
Metadata
- Authors
- Iqbal, M. A., Md, S., Sahni, J. K., Baboota, S., Dang, S., & Ali, J.
- Venue
- Journal of Drug Targeting
- Publisher
- Informa UK Limited
- Published
- 2012-08-29
- Volume
- 20
- Issue
- 10
- Pages
- 813-830
- ISSN
- 1026-7158 (ISSN-L)
- 1061-186X
- 1029-2330
- OpenAlex
- W2051959623
- Cited by
- 436
- References
- 88
- FWCI
- 11.67
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.